MNV
Market News Video
MNV MNV 10 Stocks Crossing Below Book Value
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

UTHR Crosses Above Average Analyst Target
Wednesday, July 26, 9:13 AM ET, by Market News Video Staff

In recent trading, shares of United Therapeutics Corp (UTHR) have crossed above the average analyst ...

United Therapeutics Breaks Above 200-Day Moving Average - Bullish for UTHR
Friday, August 4, 11:40 AM ET, by Market News Video Staff

In trading on Friday, shares of United Therapeutics Corp (UTHR) crossed above their 200 day ...

First Week of UTHR February 2018 Options Trading
Wednesday, September 6, 10:39 AM ET, by Market News Video Staff

Investors in United Therapeutics Corp (UTHR) saw new options begin trading this week, for the ...

First Week of UTHR October 20th Options Trading
Thursday, September 7, 10:44 AM ET, by Market News Video Staff

Investors in United Therapeutics Corp (UTHR) saw new options begin trading this week, for the ...

Implied BBH Analyst Target Price: $150
Thursday, September 21, 9:40 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Bullish Two Hundred Day Moving Average Cross - ANTH

By Market News Video Staff, Friday, October 21, 4:42 PM ET
Play Video: Learn About The 200 DMA


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Friday, shares of Anthera Pharmaceuticals Inc. (NASDAQ:ANTH) crossed above their 200 day moving average of $6.28, changing hands as high as $6.89 per share. Anthera Pharmaceuticals Inc. shares are currently trading up about 14.3% on the day. The chart below shows the one year performance of ANTH shares, versus its 200 day moving average:

Anthera Pharmaceuticals Inc. 200 Day Moving Average Chart

Looking at the chart above, ANTH's low point in its 52 week range is $3.65 per share, with $9.08 as the 52 week high point that compares with a last trade of $6.89.

ANTH operates in the Biotechnology sector, among companies like Cubist Pharmaceuticals Inc. (CBST) which is up about 1.1% today, and United Therapeutics Corp (NASDAQ:UTHR) trading up by about 0.1%. Below is a three month price history chart comparing the stock performance of ANTH, versus CBST and UTHR.

ANTH,CBST,UTHR Relative Performance Chart


Free Trial: ''ETF CHANNEL FLEXIBLE GROWTH INVESTMENT PORTFOLIO''

The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.


This Article's Word Cloud:   ANTH   Above   Anthera   Average   Below   Biotechnology   CBST   Channel   Corp   Crossing   Cubist   Flexible   Free   Friday   Growth   Investment   Looking   Moving   Pharmaceuticals   Portfolio   Start   Stocks   Their   Therapeutics   Trial   UTHR   United   about   above   allocation   allows   among   anywhere   asset   average   below   bonds   chart   designed   high   moving   performance   point   portfolio   share   shares   trading   versus   week   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Stock Message Boards Stock Market Definitions
MNV

Bullish Two Hundred Day Moving Average Cross - ANTH | Market News Video | Copyright © 2008 - 2018, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.